T. Rowe Price Associates’s Global Medical REIT GMRE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $455K | Buy |
65,517
+5,079
| +8% | +$35.3K | ﹤0.01% | 2347 |
|
2025
Q1 | $529K | Sell |
60,438
-168,383
| -74% | -$1.47M | ﹤0.01% | 2230 |
|
2024
Q4 | $1.77M | Buy |
228,821
+64,164
| +39% | +$495K | ﹤0.01% | 1701 |
|
2024
Q3 | $1.63M | Buy |
164,657
+32,276
| +24% | +$320K | ﹤0.01% | 1734 |
|
2024
Q2 | $1.2M | Buy |
132,381
+1,821
| +1% | +$16.5K | ﹤0.01% | 1819 |
|
2024
Q1 | $1.14M | Buy |
130,560
+115,866
| +789% | +$1.01M | ﹤0.01% | 1852 |
|
2023
Q4 | $164K | Buy |
14,694
+908
| +7% | +$10.1K | ﹤0.01% | 2604 |
|
2023
Q3 | $124K | Buy |
13,786
+1,507
| +12% | +$13.6K | ﹤0.01% | 2618 |
|
2023
Q2 | $113K | Buy |
12,279
+721
| +6% | +$6.64K | ﹤0.01% | 2670 |
|
2023
Q1 | $106K | Buy |
11,558
+1,109
| +11% | +$10.2K | ﹤0.01% | 2674 |
|
2022
Q4 | $99K | Buy |
+10,449
| New | +$99K | ﹤0.01% | 2720 |
|